The Department of Health and Social Care (DHSC) has today (18/05/2023) granted the following initial list of price concessions for May 2023: Drug Pack size Price concession Amisulpride 100mg tablets 60 £19.60 Amisulpride 50mg tablets 60 £12.34 Benzoyl peroxide 5% / Clindamycin 1% gel 30 £11.45 Benzoyl peroxide 5% / Clindamycin 1% gel 60 £22.90 Bicalutamide [...]
The post May 2023 Price Concessions 1st Update appeared first on PSNC Website.
Chlorphenamine 2mg/5ml oral solution (150ml) was inadvertently omitted from PSNC’s final price concession update for April published on 28th April 2023. Drug Pack size Price concession Chlorphenamine 2mg/5ml oral solution 150 £3.34 All prescriptions submitted as dispensed in April 2023 will be reimbursed at £3.34 and not as printed in the Drug Tariff for April 2023. [...]
The post Price concession update for April 2023 – Chlorphenamine 2mg/5ml oral solution appeared first on PSNC Website.
National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Emerade 500 micrograms and Emerade 300 micrograms auto-injectors, due to the potential for device failure. National Patient Safety Alert Reference Number: NatPSA/2023/004/MHRA Date issued: 9th May 2023 Emerade 500 micrograms solution for injection in pre-filled syringe, PL 33616/0015 (SNOMED Code 23420111000001107) Emerade 300 micrograms [...]
The post National Patient Safety Alert: Class 1 Medicines Recall: Emerade 500 micrograms and Emerade 300 micrograms auto-injectors appeared first on PSNC Website.
The Department of Health and Social Care (DHSC) has today (28/04/2023) granted the following final list of price concessions for April 2023: Drug Pack size Price concession Amoxicillin 125mg/5ml oral suspension 100 £3.46 Amoxicillin 125mg/5ml oral suspension sugar free 100 £3.29 Baclofen 5mg/5ml oral solution sugar free 300 £5.99 Benzoyl peroxide 5% / Clindamycin 1% [...]
The post April 2023 Price Concessions Final Update appeared first on PSNC Website.
A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 9 April 2023) has been published and includes articles on: Isotretinoin (Roaccutane▼): new safety measures to be introduced in the coming months. Janus kinase (JAK) inhibitors: new measures to reduce risks of major cardiovascular eventss, malignancy, venous thromboembolism, serious infections [...]
The post MHRA Drug Safety Update April 2023 appeared first on PSNC Website.
Recent Comments